Stock NURECA NURECA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nureca Limited Bombay S.E.

Equities

NURECA

INE0DSF01015

Medical Equipment, Supplies & Distribution

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-04-26 am EDT 		5-day change 1st Jan Change
286 INR -1.04% Intraday chart for Nureca Limited +3.40% -33.10%
Feb. 24 2,010,000 Equity Shares of Nureca Limited are subject to a Lock-Up Agreement Ending on 24-FEB-2024. CI
Feb. 07 Nureca Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2021 2022 2023
Capitalization 1 6,011 13,682 2,996
Enterprise Value (EV) 1 5,192 12,799 2,008
P/E ratio 9.69 x 30.4 x -36.3 x
Yield 0.33% 0.22% -
Capitalization / Revenue 2.82 x 5.35 x 2.69 x
EV / Revenue 2.43 x 5.01 x 1.8 x
EV / EBITDA 8.47 x 23.5 x -12.2 x
EV / FCF -31.6 x 354 x 12.3 x
FCF Yield -3.16% 0.28% 8.15%
Price to Book 3.69 x 6.73 x 1.54 x
Nbr of stocks (in thousands) 10,000 10,000 10,000
Reference price 2 601.0 1,368 299.6
Announcement Date 9/7/21 8/16/22 6/28/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 5.886 619 994.3 2,135 2,555 1,113
EBITDA 1 0.2476 90.16 93.97 612.6 545.1 -165.1
EBIT 1 0.2376 89.98 93.2 611.4 540.3 -173.9
Operating Margin 4.04% 14.54% 9.37% 28.64% 21.14% -15.62%
Earnings before Tax (EBT) 1 0.2107 88.41 86.08 623.3 609.8 -107.4
Net income 1 0.1564 62.26 63.95 463.7 449.6 -82.5
Net margin 2.66% 10.06% 6.43% 21.73% 17.59% -7.41%
EPS 2 2.234 8.890 9.136 62.04 44.96 -8.250
Free Cash Flow 1 0.8985 -6.132 -103.5 -164.2 36.18 163.6
FCF margin 15.27% -0.99% -10.41% -7.69% 1.42% 14.7%
FCF Conversion (EBITDA) 362.81% - - - 6.64% -
FCF Conversion (Net income) 574.44% - - - 8.05% -
Dividend per Share - - - 2.000 3.000 -
Announcement Date 9/5/18 11/13/20 11/13/20 9/7/21 8/16/22 6/28/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 3.19 97.1 - - -
Net Cash position 1 0.36 - - 819 883 987
Leverage (Debt/EBITDA) - 0.0354 x 1.033 x - - -
Free Cash Flow 1 0.9 -6.13 -103 -164 36.2 164
ROE (net income / shareholders' equity) 86.6% 129% 55.9% 52.1% 24.5% -4.14%
ROA (Net income/ Total Assets) 7.1% 36.8% 20.3% 34.8% 16.7% -5.11%
Assets 1 2.203 169 315.1 1,333 2,695 1,615
Book Value Per Share 2 3.700 11.40 21.30 163.0 203.0 195.0
Cash Flow per Share 2 5.140 0.1600 0.1100 17.20 8.250 0.5000
Capex - 1.19 4.12 4.25 34 3.96
Capex / Sales - 0.19% 0.41% 0.2% 1.33% 0.36%
Announcement Date 9/5/18 11/13/20 11/13/20 9/7/21 8/16/22 6/28/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NURECA Stock
  4. NURECA Stock
  5. Financials Nureca Limited